Ligand validation:1HKU

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1HKU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1HKU_NAD_A_600	61%	5%	0.142	0.929	2.6	2.69	12	19	3	0	100%	1
1MX3_NAD_A_1000	85%	11%	0.098	0.963	2.08	2.08	8	12	2	0	100%	1
4U6S_NAD_A_401	76%	48%	0.114	0.95	0.8	1.18	1	4	2	0	100%	1
4LCE_NAD_A_401	67%	46%	0.143	0.95	0.83	1.23	1	6	0	0	100%	0.67
2HU2_NAD_A_600	50%	26%	0.192	0.945	1.77	1.24	3	4	2	0	100%	1
1HL3_NAD_A_600	39%	7%	0.2	0.906	2.63	2.24	11	10	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.